Suzuken | Sustainability Performance
Distributes pharmaceutical products, medical devices, and healthcare supplies, managing logistics networks for wholesale and retail customers.
1932
Japan
10,001+ employees
Wholesale
$10B+ in revenue
$100M - 500M in profitability
Submit or report inaccurate dataDownload Company InsightsⓘBy downloading this report, you'll receive the most insightful and detailed analysis of the company's sustainability performance, compared to its peers. It includes key industry trends, carbon and energy intensity, nature impact, social metrics, and an in-depth look at key risks and controversies.
Sustainability Ranking & Industry Benchmark
#9119
Overallⓘ#442
in Japanⓘ#61
in WholesaleⓘSustainability Maturity
ⓘSustainability Intent
ⓘOverview
Environmental
Energy consumptionSocial
Diversity and InclusionFinancial Data
Business performanceCapital & innovationAnalyst projections
Leading
Intensity
Energy consumption (direct) intensity (MWh /$M)
Industry Benchmark
14.0
B/M 26.8
Powered by illuminem and GIST Impact
Controversy level
- Suzuken Co Ltd, Japanese pharmaceutical wholesaler major, has faced sustained Japanese MHLW enforcement scrutiny over the contested historic 2024 Japanese pharmaceutical pricing reform pressure affecting Suzuken's distribution margins, plus periodic Japanese FSA enforcement scrutiny on inadequate disclosure of Japanese pharmaceutical distribution customer concentration affecting institutional shareholders.
